NEOM and WuXi AppTec join forces to advance pharmaceutical manufacturing in Saudi Arabia

The partnership represents a key milestone in Saudi Arabia’s push toward economic diversification and technological advancement
 

Saudi Arabia's NEOM and Chinese company sign agreement to produce pharmaceuticals in the kingdom

NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding (MoU) with WuXi AppTec, a leading global contract research, development, and manufacturing organization (CRDMO), to localize pharmaceutical research and production capabilities within the Kingdom.

Under the agreement, both entities will collaborate to explore the development of state-of-the-art CRDMO facilities at Oxagon, NEOM’s advanced and clean manufacturing hub, or other potential sites across Saudi Arabia. The initiative aligns with the country’s vision to expand its biotechnology and life sciences sectors as part of Saudi Vision 2030 and the National Biotech Strategy.

 

Read More       Biotechnology powering Saudi Vision for a sustainable future

 

Driving innovation and biotech growth

The partnership represents a key milestone in Saudi Arabia’s push toward economic diversification and technological advancement. By combining WuXi AppTec’s global expertise in biopharmaceutical innovation with NEOM’s world-class infrastructure, the collaboration seeks to build an advanced manufacturing ecosystem that benefits both regional and international markets.

The venture will leverage Oxagon’s cutting-edge facilities and sustainable manufacturing framework to foster a thriving biotech community while supporting the Kingdom’s ambition to become a global center for pharmaceutical research and production.

At its core, the partnership underscores a shared vision — uniting WuXi AppTec’s decades of global experience with NEOM’s role as a catalyst for innovation — to redefine industry standards and strengthen international collaboration in healthcare and life sciences.

 

Read More       Sascha Berger to join as NEOM's Investment Director for Biotech

 

Strengthening international partnerships

Earlier this year, NEOM secured approximately $3 billion in a landmark export credit agency (ECA) financing deal with Italy’s SACE, marking NEOM’s first corporate ECA financing and the largest untied facility ever guaranteed by the Italian group.

The agreement, supported by a consortium of nine major international banks — including HSBC, Bank of China, Citi, and J.P. Morgan — will finance various NEOM initiatives and bolster collaboration with Italian businesses, particularly small and medium-sized enterprises (SMEs).

To date, Italian suppliers and contractors have contributed over $6.3 billion in contracts across NEOM projects, highlighting the region’s growing global partnerships that support infrastructure, urban development, and technology-led industries.

Source: Economy Middle East

Post a Comment

0 Comments